| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |